<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51">
 <label>51.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Haschke</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Schuster</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Poglitsch</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Loibner</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Salzberg</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Bruggisser</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects</article-title>. 
  <source>Clin Pharmacokinet.</source> (
  <year>2013</year>) 
  <volume>52</volume>:
  <fpage>783</fpage>â€“
  <lpage>92</lpage>. 
  <pub-id pub-id-type="doi">10.1007/s40262-013-0072-7</pub-id>
  <?supplied-pmid 23681967?>
  <pub-id pub-id-type="pmid">23681967</pub-id>
 </mixed-citation>
</ref>
